Download presentation
Published bySophie Tate Modified over 9 years ago
1
Polyneuropathies Mononeuropathies Motoneuron diseases
Zsuzsanna Arányi
2
Peripheral nerve Motor, sensory and autonomic fibers
Fiber types according to diameter: A fibers μm in diameter; myelinated motor and sensory fibers B fibers- 1-3 μm in diameter; myelinated autonomic fibers C fibers μm in diameter; non-myelinated autonomic and pain fibers
3
Types of peripheral nerve damage
Demyelination Slowed conduction: no symptoms Conduction block: weakness and sensory loss, but no atrophy Axonal damage (axonotmesis) Degeneration of axons distal to the lesion (denervation) Weakness, sensory loss, atrophy Neurotmesis Damage to axons and epineurium No regeneration without nerve suture
4
Nerve regeneration – reinnervation
Remyelination Proximo-distal axon regeneration Collateral reinnervation (in case of partial nerve damage) 2-12 weeks 1 mm/day Intact basal lamina/endoneurium is needed Starts within 4-6 weeks
5
Polyneuropathies Generalised disease of the peripheral nervous system (nerve roots and peripheral nerves) Usually the longest nerves are affected first Symptoms start on the toes, feet Usually the symptom of an underlying systemic disease Search for etiology!
6
Classification of polyneuropathies
Clinical presentation Symmetric Asymmetric Time course Acute Chronic Etiology Pathology Axonal Demyelinative Small-fiber
7
Clinical forms of polyneuropathies
Chronic, symmetric, distal and predominantly sensory polyneuropathies Mononeuropathy multiplex Purely motor or sensory polyneuropathies Autonomic polyneuropathies Acute polyneuropathies
8
Typical symptoms of polyneuropathies
Chronic course Symmetric, distal paraesthesia, pain and hypaesthesia in stocking – glove distribution; feet are affected first Allodynia Depressed or absent tendon reflexes Distally pronounced muscle weakness, with wasting, fasciculation Gait disorder Sensory ataxia Weakness Autonomic dysfunction (reduced sweating, tachycardia, urinary disturbances, gastroparesis etc.)
9
Typical complaints of patients with polyneuropathies
Tingling, pin-prick, numbness, burning or cold sensation, burning pain (especially during the night) ‘Ants crawling on my legs’ ‘As if I had tight boots on’ ‘As if I were walking on a duvet’ ‘As if I had stockings on when really not’ ‘As if my skin were thick on my soles’ Unstable gait, ‘dizziness’ Loss of dexterity of the hands: ‘I drop objects’
10
Causes of polyneuropathy
Metabolic-endocrine disturbances: diabetes mellitus, uremia etc. Vitamin deficiencies: vitamin B1 -alcoholism, malabsorption, malnutrition, vitamin B12 Toxic causes: heavy metals, industrial solvents, drugs, alcohol Dysimmune polyneuropathies With manifestation only in the peripheral nervous system: acute inflammatory demyelinative polyneuropathy (Guillain-Barré syndrome), chronic inflammatory demyelinative polyneuropathy (CIDP), multifocal motor neuropathy (MMN) Systemic diseases: vasculitis (polyarteritis nodosa, SLE etc.), paraproteinaemias Paraneoplasia Infectious: lepra, Lyme-disease, HIV Hereditary: Charcot-Marie-Tooth disease etc. Other: critical illness polyneuropathy, small-fiber neuropathy Idiopathic
11
Investigation of polyneuropathies
ENG-EMG Blood tests: We, blood count, glucose, hepatic and renal function Vitamin B12 Thyroid function Se electrophoresis, autoanti-bodies, cryoglobulin Serological examinations (HIV, Lyme, HCV) Search for tumors CSF Toxicological investigations Sural nerve biopsy Genetic tests
12
Treatment of polyneuropathies
Treat the cause! Immune therapy plasmapheresis: Guillain-Barré syndrome, CIDP immunoglobulins: MMN, Guillain-Barré syndrome, CIDP corticosteroids: CIDP, systemic vasculitis Symptomatic treatment of paraesthesias and neuropathic pain antiepileptic medications (carbamazepine, gabapentin, pregabalin) tricyclic antidepressants (amitriptilin, clomipramin) SNRI antidepressants (duloxetin, venlafaxin) Vitamin B1: alcoholism, malabsorption, malnutrition
13
Polyneuropathies associated with diabetes mellitus
Distal symmetric sensory polyneuropathy Mononeuropathies- carpal tunnel syndrome, ulnar nerve lesion Cranial nerve lesions- oculomotor nerve palsy Autonomic neuropathy- sexual and urinary disturbance, gastroparesis and diarrhoea etc. Diabetic amyotrophy- painful, asymmetric, proximal weakness (plexopathy?) Radiculopathy- lumbar, thoraco-abdominal
14
Diabetic chronic distal symmetric sensory polyneuropathy
The most common form of diabetic neuropathy Prevalence among diabetic patients: 20-60% Present at the diagnosis of diabetes in 20% of patients May be the only manifestation of impaired glucose tolerance Severity is usually proportional to the duration and severity of hyperglycemia Prevalence increases with age and duration of diabetes Small fibers (pain, temperature, light touch) are preferentially affected → painful diabetic neuropathy in about 20-35% Autonomic dysfunction Trophic alterations → diabetic foot
15
Small fiber neuropathy- skin biopsy
Normal Small fiber neuropathy Epidermal nerve fibers (arrow): anti PGP 9.5 antibodies Fibrous tissue and basal lamina: anti collagen IV antibodies
16
Symptoms of sensory diabetic neuropathy I.
Length-dependent: first symptoms on the toes and feet Later stocking-gloves distribution Usually doesn’t go above the knees and elbows If symptoms appear on the hands first → carpal tunnel syndrome Areflexia Trophic changes
17
Symptoms of sensory diabetic neuropathy II.
Positive sensory symptoms: burning pain (pronounced during the night) hyperesthesia, allodynia paresthesia Negative sensory symptoms: hypesthesia (loss of sensation)
18
Diabetic foot Related to diabetic sensory neuropathy and peripheral artery disease Diabetic foot ulcers precede 85% of non-traumatic lower limb amputations Life-time prevalence of foot ulcers is 15% in diabetic patients
19
Guillain-Barré syndrome
Acute immunmodulated poly-radiculo-neuro-pathy Pathology: perivascular lymphocyte-macrophage infiltration in the peripheral nervous system leading to macrophage mediated segmental demyelination Incidence: / /year In most cases preceded by an infection (upper respiratory tract infection, diarrhoea) Infectious agents associated with Guillain-Barré syndrome: CMV, EBV, HIV, Campylobacter jejuni, Mycoplasma pneumoniae The infectious agent is usually unidentified
20
Pathomechanism of GBS
21
Guillain-Barré syndrome- symptoms
Acute, symmetric ascending flaccid paralysis Variable severity Respiratory insufficiency Bilateral facial palsy Ascending numbness to a lesser degree Radicular pain Areflexia Autonomic symptoms- tachycardia, cardiovascular instability
22
Guillain-Barré syndrome- time course
Symptoms evolve over 1-2 weeks Plateau is reached within 2-3 weeks Spontaneous recovery within a few months Good prognosis Prognosis is determined mainly by complications of being bed-bound (infection, thrombosis etc.)
23
Guillain-Barré syndrome- diagnosis
Normal neurography Segmental demyelination Conduction block Temporal dispersion
24
Guillain-Barré syndrome- diagnosis and treatment
Clinical symptoms Electroneurography- confirms segmental demyelination Cerebrospinal fluid examination: elevated protein content with normal cell count (starting from the 2nd week) Treatment Plasmapheresis, immunoglobulin (IVIG) Supportive treatment!
25
Chronic inflammatory demyelinative polyneuropathy (CIDP)
Autoimmune disease Prevalence: 1-2/ Course: chronic monophasic (15%) chronic relapsing-remitting (34%) step-wise progressive (34%) continuously progressive (15%) Symptoms: proximal and distal motor and sensory symptoms, cranial symptoms (not a length-dependent neuropathy) Rarely associated with central nervous system demyelination (3%)
26
Diagnosis of CIDP ENG/EMG: segmental (non-uniform) demyelination
CSF: protein >45 mg/dl, cell count <10 Histology (biopsy): not obligatory, may be normal chronic demyelination-remyelination may lead to Schwann-cell proliferation (‘onion bulb’ formation) infiltration of inflammatory cells MRI: hypertrophy of peripheral nerves and nerve roots, contrast enhancement
27
CIDP- nerve biopsy ‘onion bulbs’
28
CIDP- MRI Hypertrophied trigeminal nerves
29
CIDP treatment IVIG Corticosteroids Plasmapheresis
2 g/kg bw in 2-5 days, monthly for 3 months maintanance treatment Corticosteroids methylprednisolon 1 mg/kg bw, later gradual reduction Plasmapheresis
30
Mononeuropathies- causes
Trauma cutting, laceration and stretching of the nerve Compression often iatrogenic Tunnel syndromes Ischemia
31
Localisation of focal nerve lesions
A partial proximal nerve lesion may selectively affect only one nerve fascicle → clinically the lesion appears more distal The longer axons are more sensitive to compression → distal symptoms are more pronounced
32
Median nerve
33
Distal median nerve damage: carpal tunnel syndrome
Incidence: / /year, 3 times more common in women Symptoms: Painful paraesthesia of the hand during the night, pain in the whole arm First the dominant hand is affected, but bilateral involvement in most cases Advanced symptoms: sensory loss on digits 1-3, thenar atrophy and weakness Causes: idiopathic, overuse, change of tunnel anatomy (fracture, arthrosis, oedema etc.), diabetes Treatment: Splinting of the hand during the night Surgery
34
Proximal median nerve damage
1. 1. Weakness of all median nerve muscles ‘oath hand’ 2. 2. Weakness of flexion of the distal phalanx of digit no sensory loss
35
Ulnar nerve
36
Ulnar nerve lesion at the elbow- two types
Extension Flexion Retroepicondylar lesion (more common) Compression, elbow fracture, arthrosis, diabetes Real cubital tunnel syndrome
37
Ulnar nerve lesion Numbness of digit 4-5 and ulnar edge of the hand
Atrophy and weakness of hypothenar, interosseus muscles and adductor pollicis muscle Tinel-sign at the elbow Claw hand
38
Radial nerve
39
Radial nerve lesion on the upper arm
‘Saturday night palsy’: nerve compression during sleep common in alcoholics Symptoms: weakness of wrist and finger extension (wrist drop); triceps is normal; loss of sensation on the dorsal-radial aspect of the hand
40
Radial nerve lesion on the forearm
Weakness of finger extension (‘finger drop’), extension of the wrist is only sightly weak, oftens starts on digit 4-5 → may be confused with ulnar nerve lesion No sensory loss Causes: supinator tunnel syndrome due to overuse
41
Common peroneal nerve
42
Peroneal nerve damage at the fibular head
Foot drop, steppage gate Supination (inversion) and plantarflexion is normal Sensory loss on the lateral aspect of the leg and dorsal aspect of the foot Causes: compression During sleep, in coma During surgery Cast Crossed legs Squatting (strawberry pickers) Peroneal tunnel syndrome?
43
Motoneuron diseases Progressive loss/degeneration of motoneurons
Weakness Atrophy No sensory or autonomic symptoms Two major types: Amyotrophic lateralsclerosis (ALS): both upper and lower motoneurons are affected Spinal muscular atrophies / lower motoneuron syndromes
44
ALS First described by Jean Martin Charcot in 1874
Incidence: 2 / / year Prevalence: 6 / ‘Lou Gehrig’s disease’
45
ALS- Clinical forms Classic ALS Sporadic ALS Familial ALS (5-10%)
Progressive muscular atrophy (PMA) Primary lateralsclerosis Progressive bulbar paralysis Progressive pseudobulbar palsy Familial ALS (5-10%) Autosome dominant SOD1 mutations No SOD1 mutations Autosome recessive SOD1 mutation Chronic juvenile ALS X-linked Frontotemporal dementia + ALS (ubiquitin positive) Progressive muscular atrophy (PMA) Lower motoneuron onset Classic ALS Upper motoneuron onset Bulbar onset Progressive bulbar paralysis Primary lateralsclerosis
46
ALS- symptoms and course
Mixed signs of upper and lower motor neuron lesion Atrophy, fasciculation, cramps Spasticity, increased reflexes, Babinski Relentlessly and quickly progressive Average survival: 2-5 years Cause of death: respiratory insufficiency
47
ALS- Clinical syndromes at onset
Asymmetric small hand muscle atrophy and weakness (segmental distribution) % Diff. dg.: radiculopathy, ulnar nerve lesion Proximal arm muscle atrophy and weakness (‘flail’ arm) Diff. dg.: radiculopathy Bulbar onset % Dysarthria and dysphagia Diff. dg.: myasthenia gravis, pseudobulbar paresis Spastic paraparesis Diff. dg: spinal disease
48
ALS symptoms
49
ALS- treatment No cure Only drug approved for ALS: riluzol (inhibits the presynaptic release of glutamate), survival on riluzol increases by 3-6 months Supportive treatment: Muscle relaxants Antidepressants, anxiolytic drugs PEG in case of severe dysphagia Assistive devices Ventilation??? (moral issue) Riluzol trials
50
Infantile and juvenile spinal muscular atrophies (SMA I-III)
1 / live births Autosome recessive In 95% of patients the mutation is found in the SMN (survival motoneuron) gene (chr. 5)
51
Infantile and juvenile spinal muscular atrophies (SMA I-III)
SMA I: Werdnig-Hoffmann disease. Symptoms are present at birth- ‘floppy baby’. Death within 1-2 years. SMA II.: Intermediate form SMA III: Kugelberg-Welander disease Symptoms start at age years: proximal, symmetric weakness in the legs Progression is variable Differential diagnosis: muscle dystrophies Dg.: EMG (chronic neurogenic findings), genetic testing
52
Adult onset spinal muscular atrophies / lower motoneuron diseases
SMA IV: 'adult onset' proximal spinal muscular atrophy Onset: years of age Inheritance: 70% AR, 30% AD Gene is unknown Symptoms: very slowly progressive limb girdle weakness and atrophy. May be asymmetric, the quadriceps muscle is very often affected. No bulbar involvement. Differential diagnosis: muscle dystrophies, ALS
53
Adult onset spinal muscular atrophies / lower motoneuron diseases
dSMA V: 'adult onset' distal spinal muscular atrophy Onset: years of age Inheritance : AD Gene is unknown Symptoms : slowly progressive distal weakness and atrophy Differential diagnosis: polyneuropathies
54
Adult onset spinal muscular atrophies / lower motoneuron diseases
Benign focal amyotrophy Usually sporadic More common in men Starts in young adulthood, slow progression over a few years, then stagnation Symptoms: small hand atrophy on one side Differential diagnosis: ALS, ulnar nerve lesion
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.